Clinical Trial

Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The standard method for localizing non-palpable breast cancer is currently preoperative wire-guided localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of wire vs. combined breast tissue markers in localizing non-palpable breast cancer.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05797454
Lead Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions Breast Cancer, Breast-conserving Surgery
Enrollment 170 participants
Start Date 2023-02-17
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-03